Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease - The Conversation

Breakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease  The ConversationDaraxonrasib Doubles Survival in Pancreatic Cancer at ASCO 2026: A Game-Changer  Oncology News Central‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long  The Washington PostPromising new treatment for pancreatic cancer doubles survival rates  PBSThis Pancreatic Cancer Drug Is So Good, It Got a Standing Ovation  Bloomberg.com